A study showed that Americans have a high chance of becoming infected with the herpes virus. (1)

ROCHESTER, NEW YORK, UNITED STATES, May 26, 2015 /EINPresswire.com/ --


“Infected with the herpes simplex virus (HSV-1 or HSV-2)? The CBCD recommends taking Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

Infection with the herpes virus (HSV-2) is a growing health problem for millions of people worldwide, but especially in America. In fact, according to a study in the respected journal PLoS One, infection rates in the Americas are the second highest in the world. Dr. Katharine Looker said that “More women are infected with the disease than men – in 2012, it was estimated that 267 million women and 150 million men were living with the infection. In 2012, prevalence was estimated to be highest in Africa followed by the Americas, but high rates were seen across all regions, making herpes a global public health concern.” (1) Dr. Looker is from the University of Bristol.

Dr. Lori Newman from the World Health Organization (WHO) said that “The ultimate tool to prevent herpes is the development of a vaccine, but global partners will have to commit resources to help develop an effective vaccine that can be made available to people all over the world.” (1)

However, the Center for the Biology of Chronic Disease (CBCD) points out that there are no herpes vaccines on the market today, although scientists around the globe are working furiously to develop one. Dr. William Jacobs, Jr., a lead researcher for a vaccine candidate, said that “Developing a herpes vaccine is one of the holy grails of infectious disease research.” (2)

However, developing an effective, therapeutic vaccine against the genital herpes virus (HSV-2) and gaining FDA approval takes time. Until companies working on anti-herpes vaccines are able to successfully test them and gain FDA approval, the CBCD recommends that infected individuals take Gene-Eden-VIR or Novirin, which are natural herpes remedies with a formula backed by clinical studies.

Click to learn more about herpes symptoms.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the formula is effective against the herpes family of viruses, including HSV-1 and HSV-2. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with (the formula of Novirin).” (2) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)

Gene-Eden-VIR and Novirin can be ordered online on their product websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims. Note: Novirin has the same formula as Gene-Eden-VIR. However, it contains higher quality and more expensive ingredients.

“Herpes simplex virus (HSV) infections impose an enormous health burden on the world’s population, making the development of an HSV vaccine a top public health priority. HSV-1 is the leading cause of corneal blindness worldwide and has emerged as the predominant cause of genital disease in the developed world. HSV-2 is the leading cause of genital ulcerative disease, and its high prevalence in sub-Saharan Africa contributes significantly to the spread of HIV-1 in this region. Moreover, HSV can lie dormant (or latent) in neurons for months or years before becoming active, so the health of infected individuals can be affected for life. There is, therefore, an urgent need for an effective HSV vaccine that can provide protection against infection and also prevent the virus entering a latent state.” (3)

What treatments are currently available for those infected with the herpes virus?

“Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (2)

The CBCD points out that there are also the natural antiviral products, Gene-Eden-VIR and Novirin, with a formula designed to help the immune system target the latent HSV in those already infected. Additionally, two separate post-marketing clinical studies found that their formula reduced the symptoms of HSV infected individuals. (2)

“We believe a vaccine that is effective against both the active and latent herpes virus will be a medical breakthrough. But, in light of the fact that there are no vaccines against the herpes virus currently on the market, the CBCD recommends that HSV infected individuals take Gene-Eden-VIR or Novirin against the latent HSV.” - Greg Bennett, CBCD

Those interested in learning new and interesting facts on herpes infection are encouraged to like the Gene-Eden-VIR Facebook page, here:

https://www.facebook.com/GeneEdenVIR

Follow us on Twitter, here: @HananPolansky

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) World Health Organization - Sexual and reproductive health - "Call for more research and greater efforts to prevent and control the spread of herpes simplex virus."
http://www.who.int/reproductivehealth/topics/rtis/hsv2-estimates/en/

(2) Polansky, H., Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013. http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.VH2qQNKUf90

(3) Elifesciences.org - Bolland, S., Pierce,S. “Ups and downs in the search for a Herpes simplex virus vaccine.” Published March 10, 2015.
http://elifesciences.org/content/elife/4/e06883.full.pdf

Hanan Polansky
Lilac Corp.
5852509999
email us here